bumetanide has been researched along with Lung Diseases in 1 studies
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Half-life and mean residence time decreased markedly in the first month of life (p < 0." | 2.68 | Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants. ( Blumer, JL; Myers, CM; Sullivan, JE; Witte, MK; Yamashita, TS, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sullivan, JE | 1 |
| Witte, MK | 1 |
| Yamashita, TS | 1 |
| Myers, CM | 1 |
| Blumer, JL | 1 |
1 trial available for bumetanide and Lung Diseases
| Article | Year |
|---|---|
Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants.
Topics: Aging; Bumetanide; Critical Illness; Diuretics; Female; Heart Diseases; Humans; Infant; Infant, Newb | 1996 |